Who owns Edwards Lifesciences Corp (EW)? Elite investor 13F holders
8 tracked elite investors reported holding Edwards Lifesciences Corp as of 2026-06-30, including Aristotle Capital Management, Bridgewater Associates, Gotham Asset Management, Wedgewood Partners, Renaissance Technologies LLC. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
8 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Health Care Equipment & Services
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Aristotle Capital Management | EDWARDS LIFESCIENCES CORP | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 783906442.00 USD | 8665712.000000 | Shares | buy | Original filing |
| Viking Global Investors | EDWARDS LIFESCIENCES CORP | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| Bridgewater Associates | EDWARDS LIFESCIENCES CORP | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 24901738.00 USD | 275279.000000 | Shares | add | Original filing |
| Gotham Asset Management | EDWARDS LIFESCIENCES CORP | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 9070515.00 USD | 100271.000000 | Shares | reduce | Original filing |
| Wedgewood Partners | EDWARDS LIFESCIENCES CORP | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 14944716.00 USD | 165208.000000 | Shares | reduce | Original filing |
| Renaissance Technologies LLC | EDWARDS LIFESCIENCES CORP | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 1899660.00 USD | 21000.000000 | Shares | reduce | Original filing |
| GMO | EDWARDS LIFESCIENCES CORP | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 1869265.00 USD | 20664.000000 | Shares | add | Original filing |
| Torray Funds | EDWARDS LIFESCIENCES CORP | SHARE | 2026-06-30 | 2026-07-30 00:00:00 | 270837.00 USD | 2994.000000 | Shares | hold | Original filing |
| Ancora Advisors / Ancora Holdings | EDWARDS LIFESCIENCES CORP | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 4071.00 USD | 45.000000 | Shares | reduce | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.